Skip to main content

Archive

COVID-19 survivors at risk of neurological and psychiatric disorders

A new study shows 1 in 3 survivors of COVID-19 received a neurological or psychiatric diagnosis within 6 months. The risk was greater in people who had severe COVID-19, but 1 in 9 patients not requiring hospitalisation, also received a diagnosis.


How research has kept calm and carried on over a year of lockdown

Over the last year many in the Oxford Health Research and Development team have been asked to work from home. But lockdown restrictions have not slowed the pace of research at the trust. 


Seven in ten patients hospitalised with COVID-19 not fully recovered five months after discharge

A majority of survivors who left hospital following COVID-19 had not fully recovered five months after discharge and continued to experience negative impacts on their physical and mental health, as well as their ability to work, according to results released by a major national study into the longer-term effect of the COVID-19.


New transatlantic partnership to transform research and clinical landscapes in mental health

A new agreement between Oxford Health NHS Foundation Trust, the University of Oxford, the University of Toronto and the Centre for Addiction and Mental Health (CAMH) in Toronto, has been formalised with the signing of a Memorandum of Understanding between the four organisations.


COVID-19: research suggests large number of infection survivors will experience cognitive complications

A research review led by Oxford Brookes University has found a large proportion of COVID-19 survivors will be affected by neuropsychiatric and cognitive complications


Training and volunteer opportunity: Community research

Three volunteers wanted for a community action research project to help improve health outcomes for Black, Asian and minority ethnic communities


Professor John Geddes appointed WA Handley Chair of Psychiatry

Professor John Geddes, Director of Research at Oxford Health and Director of the Oxford Health Biomedical Research Centre, has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021. He will be a fellow of Merton College. A donation from the WA Handley Trust endowed the first … Read more


Working in COVID-19 research: running a vaccine study

Angela Minassian is the principal investigator on a trial of a COVID-19 vaccine developed by US company Novavax, which has recruited 463 participants at the NIHR cognitive health Clinical Research Facility, based at Oxford’s Warneford Hospital


Parental Mental Health Worse Since New National Restrictions

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents. 


Thousands of participants take part in Oxfordshire COVID-19 research

Oxford’s role in vital research in response to pandemic.